Immediate Impact
1 by Nobel laureates 1 from Science/Nature 73 standout
Citing Papers
Targeting p53 pathways: mechanisms, structures and advances in therapy
2023 Standout
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout
Works of Michael Pacini being referenced
Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study
2016
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael Pacini | 72 | 115 | 206 | 220 | 166 | 8 | 556 | |
| Dominique Cazals | 39 | 136 | 245 | 66 | 142 | 11 | 515 | |
| Juan Pinelli | 26 | 99 | 322 | 306 | 154 | 8 | 625 | |
| Tony Dhillon | 30 | 117 | 319 | 70 | 168 | 17 | 564 | |
| Svenja Thies | 47 | 163 | 215 | 149 | 35 | 16 | 602 | |
| Helen C. Hollingsworth | 34 | 296 | 162 | 133 | 140 | 8 | 591 | |
| Susan P. Hubbard | 22 | 106 | 153 | 124 | 79 | 9 | 567 | |
| A. B. Lopez | 33 | 46 | 244 | 176 | 145 | 8 | 490 | |
| Muriel Belotti | 45 | 204 | 323 | 42 | 72 | 6 | 545 | |
| E.S. Lambright | 23 | 86 | 104 | 108 | 31 | 6 | 629 | |
| Cynthia Helsabeck | 25 | 105 | 224 | 126 | 127 | 14 | 538 |
All Works
Loading papers...